Clinical Trials Directory

Trials / Completed

CompletedNCT00742781

Vitamin D Supplementation in Crohn's Patients

Vitamin D and Crohn's Disease" From the Bench to the Clinic

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Penn State University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effect of vitamin D supplementation in Crohn's disease patients. Patients will be evaluated for increases in circulating vitamin D levels and effects on health benefits including improved bone markers, Crohn's disease activity scores, and inflammatory markers.

Detailed description

The incidence of autoimmune diseases like inflammatory bowel disease (IBD) has increased in developed countries over the last 50 years. We propose that decreased outdoor activity and increased pollution and diets that lack adequate vitamin D have combined to create large fluctuations in vitamin D status in developed countries and especially in populations that experience winter. Experimentally we've shown that changes in vitamin D status results in more severe forms of experimental IBD. In addition, active vitamin D (1,25(OH)2D3) completely blocks the development of experimental IBD. The vitamin D hypothesis proposes that vitamin D regulates the development and function of the immune system and that changes in vitamin D status affect the development of the resultant immune response and the development of diseases like IBD. Our hypothesis is that because of low dietary vitamin D intakes and malabsorption of many nutrients, Crohn's patients will have low circulating vitamin D levels that are detrimental for their health. We plan to give Crohn's patients 1000 IU of vitamin D/d and determine whether this dose is well tolerated, induces an increase in circulating vitamin D levels and has any additional health benefits (improved bone markers, Crohn's disease activity scores, inflammatory markers).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin DOral supplementation daily with up to 5000 IU over 6 months.

Timeline

Start date
2009-05-01
Primary completion
2011-08-01
Completion
2011-12-01
First posted
2008-08-28
Last updated
2013-07-26
Results posted
2013-07-01

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00742781. Inclusion in this directory is not an endorsement.